EGFR and neoplasm: PD-L1 expression did not show statistically significant differences across various patient groups categorized by age, gender, history of alcohol consumption, TNM stage, tumor differentiation, MMR status, CD8-positive T cell infiltration, EGFR status, and prior history of targeted/immunotherapy (all P>0.05).